These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9241021)

  • 1. Effectiveness of clomipramine for obsessive-compulsive symptoms and chronic pain in two patients with schizophrenia.
    Kurokawa K; Tanino R
    J Clin Psychopharmacol; 1997 Aug; 17(4):329-30. PubMed ID: 9241021
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
    Margetić B; Aukst-Margetić B; Jakovljević M
    Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
    [No Abstract]   [Full Text] [Related]  

  • 3. Ineffectiveness of clomipramine for obsessive-compulsive symptoms in a patient with schizophrenia.
    Bark N; Lindenmayer JP
    Am J Psychiatry; 1992 Jan; 149(1):136-7. PubMed ID: 1728163
    [No Abstract]   [Full Text] [Related]  

  • 4. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 5. Clomipramine-induced tourettism in obsessive-compulsive disorder: clinical and theoretical implications.
    Moshe K; Iulian I; Seth K; Eli L; Joseph Z
    Clin Neuropharmacol; 1994 Aug; 17(4):338-43. PubMed ID: 9316681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF; Correa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment for late-onset obsessive-compulsive disorder with parkinsonism.
    Agarwal A; Biswas D; Sadhu R
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):331-6. PubMed ID: 18806237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
    Cheung EF
    Aust N Z J Psychiatry; 2001 Oct; 35(5):695-6. PubMed ID: 11551293
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined lithium-tricyclic treatment of obsessive-compulsive disorder.
    Golden RN; Morris JE; Sack DA
    Biol Psychiatry; 1988 Jan; 23(2):181-5. PubMed ID: 3334887
    [No Abstract]   [Full Text] [Related]  

  • 11. Clomipramine for obsessive-compulsive symptoms in schizophrenia.
    Tejera CA; Mayerhoff DI; Ramos-Lorenzi J
    J Clin Psychopharmacol; 1993 Aug; 13(4):290-1. PubMed ID: 8376620
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy of obsessive-compulsive disorder.
    Klein DF
    Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melasma: A rare adverse effect of clomipramine.
    Kar SK
    Indian J Pharmacol; 2016; 48(4):453-454. PubMed ID: 27756961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of obsessive-compulsive disorder using clomipramine in a very old patient.
    Trappler B
    Ann Pharmacother; 1999 Jun; 33(6):686-90. PubMed ID: 10410180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns regarding study of obsessive-compulsive disorder in dogs.
    Overall KL
    J Am Vet Med Assoc; 1998 Jul; 213(2):198-9. PubMed ID: 9676584
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV
    J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
    Berman I; Sapers BL; Chang HH; Losonczy MF; Schmildler J; Green AI
    J Clin Psychopharmacol; 1995 Jun; 15(3):206-10. PubMed ID: 7635998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-response by age at onset in obsessive-compulsive disorder.
    Fontenelle LF; do Rosário-Campos MC; Mendlowicz MV; Ferrão YA; Versiani M; Miguel EC
    J Affect Disord; 2004 Dec; 83(2-3):283-4. PubMed ID: 15555726
    [No Abstract]   [Full Text] [Related]  

  • 20. The assessment of drugs in obsessional states.
    Philpott R
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):91-5. PubMed ID: 973952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.